cisplatin injection, solution
fosun pharma usa inc - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) - cisplatin injection is indicated as therapy to be employed as follows: metastatic testicular tumors in established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and/or radio therapeutic procedures. metastatic ovarian tumors in established combination therapy with other approved chemotherapeutic agents in patients with metastatic ovarian tumors who have already received appropriate surgical and/or radiotherapeutic procedures. an established combination consists of cisplatin and cyclophosphamide. cisplatin injection, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received cisplatin injection therapy. advanced bladder cancer cisplatin injection is indicated as a single agent for patients with transitional cell bladder cancer which is no longer amenable to local treatments, s
cisplatin teva 1 mg/ml concentrate for soln for inf
teva pharma b.v. - cisplatin - concentrate for soln for inf - 1 mg/ml - platinum compounds
cisplatin 50mg/50ml concentrate for solution for infusion vials
accord-uk ltd - cisplatin - solution for infusion - 1mg/1ml
cisplatin 10mg/10ml concentrate for solution for infusion vials
accord-uk ltd - cisplatin - solution for infusion - 1mg/1ml
cisplatin 100mg/100ml concentrate for solution for infusion vials
accord-uk ltd - cisplatin - solution for infusion - 1mg/1ml
cisplatin-asteria inj. 50mg/50ml
hankook korus pharm co. - cisplatin - solution for injection - 1mg/ml
cisplatin-asteria inj. 50mg/50ml solution for i/v injection
hankook korus pharm co. - cisplatin - solution for i/v injection - 1mg/ml
cisplatin 1 mg/ml concentrate for soln for inf
caduceus pharma ltd - cisplatin - concentrate for soln for inf - 1 mg/ml - platinum compounds
cisplatin 1 mg/ml concentrate for solution for infusion
cipla (eu) limited - cisplatin. - concentrate for solution for infusion - 1mg/ml - other antineoplastic agents, pla - for the treatment of: • advanced or metastatic testicular cancer • advanced or metastatic ovarian cancer • advanced or metastatic bladder carcinoma • advanced or metastatic squamous cell carcinoma of the head and neck • advanced or metastatic non-small cell lung carcinoma • advanced or metastatic small cell lung carcinoma
cisplatin injection solution
omega laboratories limited - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents